Expression of tumor necrosis factor-α and interleukin-6 in oral squamous cell carcinoma

Japanese Journal of Cancer Research

Volumn 90, Issue 8, 1999, Pages 858-866

  Nakano, Yasuko ^a   Kobayashi, Wataru ^a   Sugai, Satoshi ^a   Kimura, Hiroto ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cytokine; In situ hybridization; Oral cancer; Treatment effects

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR VOLUME;

EID: 0032873458     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00827.x     Document Type: Article

References (36)

1. 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J. Biol. Chem., 263, 7760-7766 (1998).
2. Rak, J. W., Hegmann, E. J., Lu, C. and Kerbel, R. S. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J. Cell. Physiol., 159, 245-255 (1994).
3. Naylor, M. S., Stamp, G. W. H., Foulkes, W. D., Eccles, D. and Balkwill, F. R. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J. Clin. Invest., 91, 2194-2206 (1993).
4. McIntyre, C. A., Chapman, K., Reeder, S., Dorreen, M. S., Bruce, L. and Rodgers, S. Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants. Eur. J. Cancer, 28, 58-63 (1992).
5. Waase, I., Bergholz, M., Iglauer, A., Beissert, S., Blech, M. and Schauer, A. Heterogeneity of tumour necrosis factor production in renal cell carcinoma. Eur. J. Cancer, 28A, 1660-1664 (1992).
6. von Biberstein, S. E., Spiro, J. D., Lindquist, R. and Kreutzer, D. L. Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinoma. Am. J. Surg., 170, 416-422 (1995).
7. Kitahara, M., Kishimoto, S., Hirano, T., Kishimoto, T. and Okada, M. The in vivo anti-tumor effect of human recombinant interleukin-6. Jpn. J. Cancer Res., 81, 1032-1038 (1990).
8. Mulé, J. J., McIntosh, J. K., Jablones, D. M. and Rosenberg, S. A. Antitumor activity of recombinant interleukin 6 in mice. J. Exp. Med., 171, 629-636 (1990).
9. Pusztai, L., Lewis, C. E. and McGee, J. O. D. Growth arrest of the breast cancer cell line, T47D, by TNFα; cell cycle specificity and single transduction. Br. J. Cancer, 67, 290-296 (1993).
10. Wiseman, D. M., Polverini, P. J., Kamp, D. W. and Leibovich, S. J. Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun., 157, 793-800 (1998).
11. Mann, E. A., Hibbs, M. S., Spiro, J. D., Bowik, C., Wang, X. Z. and Clawson, M. Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumor necrosis factor-alpha. Ann. Otol. Rhinol. Laryngol., 104, 203-209 (1995).
12. Cockerill, G. W., Meyer, G., Noack, L., Vadas, M. A. and Gamble, J. R. Characterization of a spontaneously transformed human endothelial cell line. Lab. Invest., 71, 497-509 (1994).
13. de Kossodo, S., Moore, R., Gschmeissner, S., East, N., Upton, C. and Balkwill, F. R. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis. Br. J. Cancer, 72, 1165-1172 (1995).
14. Wenzel, C. T., Scher, R. L. and Richtsmeier, W. J. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links. Arch. Otolaryngol. Head Neck Surg., 121, 1279-1286 (1995).
15. Beissert, S., Bergholz, M., Waase, I., Lepsien, G., Schauer, A. and Pfizenmaier, K. Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization. Proc. Natl. Acad. Sci. USA, 86, 5064-5068 (1989).
16. Ohno, M., Kato, M., Nakamura, T. and Saitoh, Y. Gene expression for tumor necrosis factor α and its production in gastric cancer patients. Jpn. J. Cancer Res., 85, 1029-1034 (1994).
17. Pusztai, L., Clover, L. M., Cooper, K., Starkey, P. M., Lewis, C. E. and McGee, J. O. D. Expression of tumour necrosis factor α and its receptors in carcinoma of the breast. Br. J. Cancer, 70, 289-292 (1994).
18. Watson, J. M., Sensintaffar, J. L., Berek, J. S. and Martínez-Maza, O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50, 6959-6965 (1990).
19. Gallo, O., Pinto, S., Boccuzzi, S., Dilaghi, M., Gallina, E. and Attanasio, M. Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma. Laryngoscope, 102, 447-450 (1992).
20. Gallo, O., Gori, A. M., Attanasio, M., Martini, F., Giusti, B. and Boddi, M. Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer. Br. J. Cancer, 68, 465-468 (1993).
21. Yamamoto, T., Yoneda, K., Ueta, E. and Osaki, T. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg. Oral Med. Oral Pathol., 78, 727-735 (1994).
22. Yoneda, K., Yamamoto, T., Ueta, E., Nakao, K. and Osaki, T. Influence of aging and chemoradiotherapy on leukocyte function in oral cancer patients. Eur. J. Cancer B Oral Oncol., 31B, 144-150 (1995).
23. Spiessel, B., Beahrs, O. H., Hermanek, P., Hutter, R. V. P., Scheibe, O., Sobin, L. H. and Wagner, G. "TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours," pp. 4-17 (1992). Springer, Berlin, Heidelberg, New York.
24. Anneroth, G., Batsakis, J. and Luna, M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand. J. Dent. Res., 95, 229-249 (1987).
25. Shimosato, Y., Oboshi, S. and Baba, K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn. J. Clin. Oncol., 1, 19-35 (1971).
26. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
27. van Belkum, A., Linkels, E., Jelsma, T., van den Berg, F. M. and Quint, W. Non-isotopic labeling of DNA by newly developed hapten-containing platinum compounds. Biotechnology, 16, 148-153 (1994).
28. Parks, R. R., Yan, S. D. and Huang, C. C. Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma. Laryngoscope, 104, 860-864 (1994).
29. + T lymphocytes and human squamous cell carcinoma of the head and neck. Cell. Immunol., 177, 35-48 (1997).
30. Younes, F., Quartey, E. L., Kiguwa, S. and Partridge, M. Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma. Oral Dis., 2, 25-31 (1996).
31. Spriggs, D. R., Imamura, K., Rodriguez, C., Sariban, E. and Kufe, D. W. Tumor necrosis factor expression in human epithelial tumor cell lines. J. Clin. Invest., 81, 455-460 (1988).
32. Yamamoto, T., Yoneda, K., Ueta, E., Hirota, J. and Osaki, T. Serum cytokine levels in patients with oral mucous membrane disorders. J. Oral Pathol. Med., 20, 275-279 (1991).
33. Yamamoto, T., Osaki, T., Yoneda, K. and Ueta, E. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J. Oral Pathol. Med., 23, 309-315 (1994).
34. Bando, Y., Henderson, B., Meghji, S., Poole, S. and Harris, M. Immunohistochemical localization of inflammatory cytokines and vascular adhesion receptors in radicular cysts. J. Oral Pathol. Med., 22, 221-227 (1993).
35. Ohta, Y., Katayama, I., Funato, T., Yokozeki, H., Nishiyama, S. and Hirano, T. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch. Dermatol. Res., 283, 351-356 (1991).
36. 2+ concentration and DNA fragmentation. Cancer Res., 52, 1342-1346 (1992).